A new study linking the tetanus-diphtheria vaccine to a rare autoimmune disorder raises questions about the risk the vaccine may pose to adults. The study, published Jan. 16 in Cureus, focuses on a single case study: a previously healthy 48-year-old woman who developed immune thrombocytopenia one week after receiving the vaccine. | 
